Sec Form 13D Filing - CITIC Capital Holdings Ltd filing for China Biologic Products Inc. (CBPO) - 2020-04-08

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

 

  UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
_____________________________

 

  SCHEDULE 13D/A  

 

Under the Securities Exchange Act of 1934

 

(Amendment No. 6)*

 

China Biologic Products Holdings, Inc.

(Name of Issuer)

 

Ordinary Shares, par value $0.0001 per share

(Title of Class of Securities)

 

G21515104

(CUSIP Number)

 

Eric Chan

CITIC Capital Holdings Limited

28/F, CITIC Tower

1 Tim Mei Avenue

Central, Hong Kong

Tel: 852-3710-6889

 

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

March 30, 2020

 

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13-d1(f) or Rule 13d-1(g), check the following box. ¨

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

CUSIP No. G21515104  

 

1.  

NAME OF REPORTING PERSONS

2019B Cayman Limited

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
    (A) x
    (B) ¨
3.   SEC USE ONLY
4.  

SOURCE OF FUNDS (SEE INSTRUCTIONS)

AF

5.   Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)     ¨
6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

CAYMAN ISLANDS

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.

SOLE VOTING POWER

2,743,868 Ordinary Shares (See Item 5)

8.

SHARED VOTING POWER

0

9.

SOLE DISPOSITIVE POWER

2,743,868 Ordinary Shares (See Item 5)

10.

SHARED DISPOSITIVE POWER

0

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,743,868 Ordinary Shares (See Item 5)

12.   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

7.1%*

14.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
         

  

 

 

*Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the annual report on Form 20-F (the “Form 20-F”) filed with the Securities Exchange Commission (the “SEC”) by the Issuer (as defined below) on March 12, 2020. 

 

 

CUSIP No. G21515104  

 

1.  

NAME OF REPORTING PERSONS

CITIC CAPITAL CHINA PARTNERS IV, L.P.

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
    (A) x
    (B) ¨
3.   SEC USE ONLY
4.  

SOURCE OF FUNDS (SEE INSTRUCTIONS)

OO

5.   Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)     ¨
6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

CAYMAN ISLANDS

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.

SOLE VOTING POWER

3,743,868 Ordinary Shares (See Item 5)

8.

SHARED VOTING POWER

0

9.

SOLE DISPOSITIVE POWER

3,743,868 Ordinary Shares (See Item 5)

10.

SHARED DISPOSITIVE POWER

0

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,743,868 Ordinary Shares (See Item 5)

12.   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.7%*

14.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
         

 

 

*Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020. 

  

 

CUSIP No. G21515104  

 

1.  

NAME OF REPORTING PERSONS

CCP IV GP LTD.

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
    (A) x
    (B) ¨
3.   SEC USE ONLY
4.  

SOURCE OF FUNDS (SEE INSTRUCTIONS)

AF

5.   Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)     ¨
6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

CAYMAN ISLANDS

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.

SOLE VOTING POWER

3,743,868 Ordinary Shares (See Item 5)

8.

SHARED VOTING POWER

0

9.

SOLE DISPOSITIVE POWER

3,743,868 Ordinary Shares (See Item 5)

10.

SHARED DISPOSITIVE POWER

0

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,743,868 Ordinary Shares (See Item 5)

12.   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.7%*

14.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
         

  

 

*Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020. 

 

 

CUSIP No. G21515104  

 

1.  

NAME OF REPORTING PERSONS

CITIC CAPITAL PARTNERS LIMITED

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
    (A) x
    (B) ¨
3.   SEC USE ONLY
4.  

SOURCE OF FUNDS (SEE INSTRUCTIONS)

AF

5.   Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)     ¨
6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

CAYMAN ISLANDS

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.

SOLE VOTING POWER

3,743,868 Ordinary Shares (See Item 5)

8.

SHARED VOTING POWER

0

9.

SOLE DISPOSITIVE POWER

3,743,868 Ordinary Shares (See Item 5)

10.

SHARED DISPOSITIVE POWER

0

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,743,868 Ordinary Shares (See Item 5)

12.   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.7%*

14.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
         

 

 

*Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020. 

 

 

CUSIP No. G21515104  

 

1.  

NAME OF REPORTING PERSONS

CITIC CAPITAL HOLDINGS LIMITED

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
    (A) x
    (B) ¨
3.   SEC USE ONLY
4.  

SOURCE OF FUNDS (SEE INSTRUCTIONS)

AF

5.   Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)     ¨
6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

HONG KONG

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.

SOLE VOTING POWER

3,743,868 Ordinary Shares (See Item 5)

8.

SHARED VOTING POWER

0

9.

SOLE DISPOSITIVE POWER

3,743,868 Ordinary Shares (See Item 5)

10.

SHARED DISPOSITIVE POWER

0

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,743,868 Ordinary Shares (See Item 5)

12.   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.7%*

14.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
         

 

 

*Percentage calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020. 

 

 

CUSIP No. G21515104  

 

This Amendment No. 6 to Schedule 13D (this “Amendment No. 6”) filed by 2019B Cayman, CCCP IV, CCP IV GP, CCPL and CCHL (collectively, the “Reporting Persons”) amends and supplements the Schedule 13D previously filed jointly with the SEC on June 18, 2018 (the “Initial Filing”) by CCRE Holdings Limited, CCMB and CCHL, as amended by Amendment No. 1 to the Initial Filing filed on August 27, 2018 by CCRE Holdings Limited, CCMB and CCHL (the “Amendment No. 1”), Amendment No. 2 to the Initial Filing filed on October 16, 2018 by CCCP IV, CCP IV GP, CCPL, CCHL and CCMB (the “Amendment No. 2”), Amendment No. 3 to the Initial Filing filed on October 31, 2018 (the “Amendment No. 3”) by CCCP IV, CCP IV GP, CCPL and CCHL, Amendment No. 4 to the Initial Filing filed on September 20, 2019 (the “Amendment No. 4”) by CCCP IV, CCP IV GP, CCPL and CCHL and Amendment No. 5 to the Initial Filing filed on January 24, 2020 by CCCP IV, CCP IV GP, CCPL and CCHL (the “Amendment No. 5,” together with the Initial Filing, Amendment No. 1, Amendment No. 2, Amendment No. 3 and Amendment No. 4, the “Original Schedule 13D”), with respect to the ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), of China Biologic Products Holdings, Inc., a company organized under the laws of the Cayman Islands (the “Issuer”). The Reporting Persons entered into a joint filing agreement, dated as of April 8, 2020, a copy of which is filed with this Amendment No. 6 as Exhibit 1.

 

Except as specifically provided herein, this Amendment No. 6 does not modify any of the information previously reported in the Original Schedule 13D. Capitalized terms used but not defined in this Amendment No. 6 have the respective meanings set forth in the Original Schedule 13D.

 

Item 2.Identity and Background

 

Item 2 is amended by replacing the Schedule A to the Original Schedule 13D with the Schedule A hereto and supplemented by adding the following:

 

2019B Cayman is an exempted company incorporated with limited liability under the laws of the Cayman Islands. Its principal business address is 28/F, CITIC Tower, 1 Tim Mei Avenue, Central, Hong Kong. Its principal business is investment holdings.

 

During the last five years, none of the Reporting Persons and, to the best of their knowledge, any of the persons listed on Schedule A hereto has been: (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

Item 3.Source and Amount of Funds or Other Consideration

 

Item 3 of the Original Schedule 13D is hereby amended and supplemented by adding the following at the end thereof:

 

On March 30, 2020, CCCP IV transferred 2,477,335 Ordinary Shares to its wholly-owned subsidiary, 2019B Cayman, for an aggregate purchase price of US$214 million. The source of fund is funding from an affiliate.

  

Item 5. Interest in Securities of the Issuer

  

Item 5 of the Original Schedule 13D is hereby amended and restated in its entirety to read as follows:

 

(a), (b) The following table sets forth the beneficial ownership of Ordinary Shares of the Issuer by each of the Reporting Persons as of the date hereof. 

  

 

CUSIP No. G21515104  

  

                Number of Ordinary Shares Beneficially Owned by Each Reporting Person with:
Reporting Person   Amount beneficially
owned(1)
    Percent of class(2)     Sole power
to vote or direct the vote
    Shared power to vote or to direct the vote   Sole power to dispose or to direct the disposition of     Shared power to dispose or to direct the
disposition of
    (in Ordinary Shares)                            
2019B Cayman     2,743,868(3)       7.1%       2,743,868     0     2,743,868     0
CCCP IV     3,743,868(4)       9.7%       3,743,868     0     3,743,868     0
CCP IV GP     3,743,868(5)       9.7%       3,743,868     0     3,743,868     0
CCPL     3,743,868(5)       9.7%       3,743,868     0     3,743,868     0
CCHL     3,743,868(5)       9.7%       3,743,868     0     3,743,868     0

 

 

 

(1)Beneficial ownership is determined in accordance with Rule 13d-3 of the General Rules and Regulations under the Act, as amended.

 

(2)Percentage is calculated based on the total number of 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020. 

 

(3)Includes 266,533 Ordinary Shares to be acquired from Double Double pursuant to the January 2020 SPA.

 

(4)Includes 2,743,868 Ordinary Shares beneficially owned by 2019B Cayman.

 

(5)Represents 3,743,868 Ordinary Shares beneficially owned by CCCP IV.

 

CCCP IV is the parent company of 2019B Cayman and may be deemed to have beneficial ownership of the securities held of record and deemed to be beneficially owned by 2019B Cayman.

 

Each of CCPL and CCHL may be deemed to beneficially own the Ordinary Shares beneficially owned by CCCP IV, however each such Reporting Person hereby expressly disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

 

Because of the arrangements in the Consortium Agreement, the parties to that agreement are deemed to have formed a “group” for purposes of Section 13(d)(3) of the Act, and such “group” is deemed to beneficially own an aggregate of 26,374,631 Ordinary Shares, which represents approximately 68.5% of the total number of Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the Form 20-F filed with the SEC by the Issuer on March 12, 2020. Neither the filing of this Amendment No. 6 nor any of its contents, however, shall be deemed to constitute an admission by the Reporting Persons that any of them is the beneficial owner of any of the Ordinary Shares beneficially owned in the aggregate by other members of the Buyer Consortium and their respective affiliates for purposes of Section 13(d) of the Act or for any other purpose, and such beneficial ownership is expressly disclaimed.

 

(c)       To the best of the Reporting Persons’ knowledge, except as set forth herein, there have been no transactions effected with respect to any Ordinary Shares during the past 60 days by any of the persons named in response to Item 5(a)-(b).

 

(d)       To the best knowledge of the Reporting Persons, except as set forth herein, no person (other than the Reporting Persons) is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any securities covered by this Amendment No. 6.

 

(e)       Not applicable. 

 

 

CUSIP No. G21515104  

  

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

Item 6 of the Original Schedule 13D is hereby amended and supplemented by adding the following before the last paragraph thereof:

 

The source of funds of 2019B Cayman for the transactions contemplated under its January 2020 SPA will be primarily from revolving credit facilities of CCCP IV provided by a third-party financial institution. CCCP IV obtained the revolving credit facilities from a third-party commercial bank for general working capital purposes and to facilitate investments made by CCCP IV in accordance with the terms of its partnership agreement.

 

On January 16, 2020, CCCP IV, as borrower, and CCP IV GP, as general partner, entered into a revolving facilities agreement (the “Revolving Facilities Agreement”) with SOCIÉTÉ GÉNÉRALE, as original lender. The Revolving Facilities Agreement provides for a US$170,000,000 committed revolving credit facility (“Facility A”) and a US$180,000,000 uncommitted revolving credit facility (“Facility B”, and together with Facility A, the “Revolving Facilities”), with a maturity date of January 15, 2021, which, upon CCCP IV’s request and subject to certain conditions, may be extended to January 15, 2022. Borrowings under the Revolving Facilities are subject to customary conditions. The Facilities are secured by undrawn capital commitments of the limited partners of CCCP IV (including the right to call for such capital commitments) and a deposit account for the purposes of receiving capital contributions from the limited partners of CCCP IV, among other things.

 

Borrowings under each of the Revolving Facilities will bear interest at a rate per annum equal to the sum of (i) LIBOR for the relevant interest period, which may be, as selected by the borrower, one (1) week, two (2) weeks, one (1) month, two (2) months, three (3) months or six (6) months or any other period agreed to by the parties, and (ii) an applicable margin. All payments of principal and interest with respect to the Revolving Facilities will be due and payable as specified in the Revolving Facilities Agreement. CCCP IV intends to repay the borrowings under the Revolving Facilities with capital under the management of its affiliate. The Revolving Facilit ies Agreement contains representations and warranties, affirmative and negative covenants, including financial maintenance covenants, and events of default, that CCCP IV believes are usual and customary for such credit facilities.

 

The foregoing summary of the Revolving Facilities Agreement does not purport to be complete and is qualified in its entirety by reference to the Revolving Credit Agreement itself, a copy of which is attached hereto as Exhibit 5 and incorporated herein by reference in its entirety.

 

Item 7. Materials to be Filed as Exhibits.

  

Item 7 of the Original Schedule 13D is hereby amended and supplemented by adding the following after the last paragraph thereof:

 

  Exhibit 1 Joint Filing Agreement, dated April 8, 2020, by and among the Reporting Persons
     
  Exhibit 5† Revolving Facilities Agreement, dated January 16, 2020 by and between CCCP IV as borrower, CCP IV GP as general partner and Société Générale, as original lender

 

 

  

Portions of this Exhibit have been redacted because confidential treatment for those terms has been requested. The redacted materials have been separately provided to the SEC, and the redacted portions have been marked at the appropriate places with three asterisks inside of brackets “[***]”.

 

 

CUSIP No. G21515104  

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: April 8, 2020

 

  2019B CAYMAN LIMITED  
             
             
  By:   /s/ Rikizo Matsukawa  
      Name:   Rikizo Matsukawa  
      Title:   Director  
             
  CITIC Capital China Partners IV, L.P.  
     
  By: CCP IV GP LTD., its General Partner  
             
             
  By:   /s/ Chan Kai Kong  
      Name:   Chan Kai Kong  
      Title:   Director  
             
  CCP IV GP LTD.  
             
             
  By:   /s/ Chan Kai Kong  
      Name:   Chan Kai Kong  
      Title:   Director  
             
  CITIC CAPITAL PARTNERS LIMITED  
             
             
  By:   /s/ Chan Kai Kong  
      Name:   Chan Kai Kong  
      Title:   Director  
             
  CITIC CAPITAL HOLDINGS LIMITED  
             
             
  By:   /s/ Yichen Zhang  
      Name:   Yichen Zhang  
      Title:   Director  
             

 

 

[Signature page to the Amendment No. 6 to Schedule 13D]

 

 

CUSIP No. G21515104  

 

SCHEDULE A

 

DIRECTORS AND EXECUTIVE OFFICERS OF THE REPORTING PERSONS

 

Name   Citizenship   Present Principal Occupation or Employment   Business Address
             
Zhang, Yichen   Hong Kong  

Chairman, Chief Executive Officer and Director – CCHL;

Director – CITIC Capital Partners Limited

 

28/F, CITIC Tower,

1 Tim Mei Avenue,

Central, Hong Kong

             
Matsukawa, Rikizo   Japan   Managing Director – CCHL; Director – CCP IV GP Ltd. and 2019B Cayman Limited  

28/F, CITIC Tower,

1 Tim Mei Avenue,

Central, Hong Kong

             
Chew, Boon Lian   Singapore   Senior Managing Director – CCHL; Managing Partner –  CITIC Capital Partners Limited  

28/F, CITIC Tower,

1 Tim Mei Avenue,

Central, Hong Kong

             
Fung Yee Man, Annie   Britain   Chief Operating Officer and Senior Managing Director – CCHL  

28/F, CITIC Tower,

1 Tim Mei Avenue,

Central, Hong Kong

             
Chan, Kai Kong   Singapore   Chief Financial Officer and Senior Managing Director – CCHL; Director – CITIC Capital Partners Limited, CCP IV GP Ltd. and 2019B Cayman Limited  

28/F, CITIC Tower,

1 Tim Mei Avenue,

Central, Hong Kong

             
Zhang, Haitao   China   Director, Vice Chairman, President and Head of Asset Management – CCHL  

28/F, CITIC Tower,

1 Tim Mei Avenue,

Central, Hong Kong

             
Al Kuwari, Abdulla Ali M A   Qatar   Director – CCHL; Principal – Qatar Investment Authority  

Qatar Investment Authority

5th Floor, Q-Tel Tower,

Diplomatic St,

PO Box 23224, Doha, Qatar

             
Chen, I-hsuan   Taiwan   Director – CCHL; Senior Assistant Vice President – Fubon Life Insurance Co., Ltd.  

Fubon Life Insurance Co., Ltd.

9F, No. 108, Section 1,

Dunhua South Road,

Taipei, 10557,

Taiwan, R.O.C.

  

 

CUSIP No. G21515104  

 

DIRECTORS AND EXECUTIVE OFFICERS OF THE REPORTING PERSONS

 

 

Name   Citizenship   Present Principal Occupation or Employment   Business Address
             
Mitchell, James Gordon   Britain   Director – CCHL; Chief Strategy Officer and Senior Executive Vice President – Tencent Holdings Limited  

Tencent Holdings Limited

29F, Three Pacific Place,

Wanchai, Hong Kong

             
Lin, Yun-Ku   Taiwan   Director – CCHL; Senior Vice President – Fubon Life Insurance Co., Ltd.  

Fubon Life Insurance Co., Ltd.

9F, No. 108, Section 1,

Dunhua South Road,

Taipei, 10557,

Taiwan, R.O.C.

             
Al-Sowaidi Mohammed, Saif SS   Qatar   Director – CCHL; Head (New York) – Qatar Investment Authority  

Qatar Investment Authority

9 West 57th Street,

34th Floor, New York,

NY 10019, USA

             
Cheung, Miu   Australia   Senior Managing Director and Managing Partner of Structured Investment and Finance – CCHL   28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
             
Ching, Hiu Yuen   Hong Kong   Senior Managing Director and Managing Partner of Real Estate – CCHL   28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
             
Allegaert, Hans Omer   Belgium   Executive Director – CITIC Capital Partners Limited; Director – CCP IV GP Ltd. and 2019B Cayman Limited   28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
             
Xu, Zhichao   China   Vice Chairman, Head of Special Situations and President of CITIC Capital (Ningbo) Investment Management – CCHL   28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong
             
Xin, Yuesheng   China   Senior Managing Director – CCHL; Managing Partner – CITIC Capital Partners Limited  

28/F, CITIC Tower,

1 Tim Mei Avenue,

Central, Hong Kong

             
Zhan, Weibiao   China   Director – CCHL; Managing Director – Tencent Investment   28/F, CITIC Tower,
1 Tim Mei Avenue,
Central, Hong Kong